Medical Trial Searches Delay Treatment For Nearly 75% Of Physicians

Navigating the scientific trial panorama has turn into a big bottleneck in affected particular person care, with 72% of US physicians reporting that time-consuming searches for associated trials are delaying remedy entry. As a result of the number of scientific trials and investigational drugs continues to surge, physicians face rising frustration with outdated, fragmented devices that complicate affected particular person enrollment. Primarily based on a model new myTomorrows report, the widening gap between medical innovation and scientific trial entry underscores an urgent need for smarter, AI-powered choices to streamline trial matching and referral processes—lastly accelerating affected particular person entry to novel therapies.¹

“Navigating the scientific trial panorama is often superior, time-consuming, and worsening for every victims and physicians,” said Michel van Harten, MD, CEO, myTomorrows, in a press launch. “That’s the reason it is necessary that healthcare professionals and victims have trusted devices that make discovering the right scientific trials faster, simpler, and additional clear.”

Key Findings From the myTomorrows Survey

Completely different notable findings from the survey, which featured 100 physicians, embrace:

• Sixty-one p.c of physicians reported that discovering and accessing relevant trials is troublesome due to fragmented strategies, outdated registries, and overly superior eligibility protocols—challenges that notably affect underserved populations.
• An estimated 72% reported that they see value in a single, streamlined provide for all related scientific trials.
• Notably, 35% acknowledged that they use GenAI devices when looking for scientific trials, whether or not or not it’s for trial discovery, evaluation, or scientific reasoning.
• Spherical 61% acknowledged that they think about GenAI devices may be trusted with reference to wanting scientific trials.
• Sixty-five p.c of physicians acknowledged that they regarded for plenty of scientific trials as a lot as 10 situations so far yr.
• Nearly 30% reported that they regarded for scientific trials wherever from 11 to 50 situations contained in the earlier yr, with 87% using Google, 64% using specialist scientific trial search platforms, and 17% using GenAI devices equal to ChatGPT.
• In the case of course of, 72% said that looking for associated scientific trials is simply too time-consuming, with 56% reporting that the scientific trial course of is refined and too gradual.

Physician Views on Potential Choices

• Regarding choices for the problem, 65% found that AI-assisted pre-screening devices have been helpful. Furthermore, 63% felt the equivalent about affected particular person navigation firms, whereas 53% reported precise search filters to be helpful.
• Forty-four p.c reported institutional help from healthcare strategies and 14% reported that further frequent trial updates from sponsors have been helpful.

A Rising Gap Between Innovation and Entry

Primarily based on myTomorrows, whereas scientific trials are vital to bringing new therapies to victims, the rising amount—now exceeding 500,000 globally with better than 8,000 drugs in enchancment—has made it increasingly troublesome for physicians to find out and enroll eligible victims. The tactic stays largely information and fragmented, creating added burden for healthcare suppliers and reducing visibility into applicable trial selections. In consequence, every affected particular person entry to cutting-edge therapies and the broader tempo of therapeutic enchancment are being slowed.¹

“At myTomorrows, we’re devoted to elevating physicians’ voices and creating smart, human-centered choices that enhance entry to remedy selections,” continued van Harten, throughout the press launch. “Our AI-powered know-how streamlines every step of the strategy, connecting stakeholders in a further equitable scientific trial ecosystem, one which delivers important affect for victims, every for the time being and ultimately.”

Check out our May interview with van Harten proper right here.

References

1. Nearly 75% of Physicians Say Time-Consuming Medical Trial Searches Delay Affected particular person Treatment, New myTomorrows Report Reveals. PR Newswire. July 17, 2025. Accessed July 23, 2025. https://prnmedia.prnewswire.com/news-releases/nearly-75-of-physicians-say-time-consuming-clinical-trial-searches-delay-patient-treatment-new-mytomorrows-report-reveals-302507796.html
2. Looking for choices. myTomorrows. Accessed July 23, 2025. https://mytomorrows.com/wp-content/uploads/2025/07/Looking-for-solutions-myTomorrows-data-report-July-2025-1.pdf?utm_source=press-release&utm_medium=affiliate&utm_campaign=59_usa_en_psr_organic_awr_afi_hcp-survey-report-press-release2&utm_content=59_hcp-survey-report_txt_